-
Edesa Biotech Announces Upcoming Conference Schedule
31 Oct 2025 20:30 GMT
… , 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical … @edesabiotech.com. About Edesa Biotech, Inc. Edesa Biotech, Inc. (Nasdaq: EDSA) is … company’s most advanced Respiratory drug candidate is paridiprubart, which is …
-
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate – Hagens Berman
31 Oct 2025 18:01 GMT
… for SLK. The clinical stage biotechnology company is focused on skin … that “we really have a drug here that can become the …
-
New antibody-drug conjugates disclosed in Kelun-Biotech patent
30 Oct 2025 20:20 GMT
…
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has divulged antibody-drug conjugates (ADCs … fragment linked to a cytotoxic drug through a linker.
BioWorld Science …
-
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding
31 Oct 2025 16:00 GMT
… development of interventions, such as drugs and vaccines, as well … collaborating with private-sector biotechnology and pharmaceutical companies to accelerate the … significantly to biodefense through nanoscale drug delivery systems, biosensors, and …
-
CDMO Services Market for Pharma and Biotech: Growth Outlook and Industry Insights (2024–2034)
31 Oct 2025 14:00 GMT
… comprehensive drug development and manufacturing services to pharmaceutical and biotechnology companies. … manufacturing across small-molecule drugs, biologics, vaccines, and … complexity of new drugs, such as antibody-drug conjugates, oligonucleotides …
-
Pharma and Healthcare Deals Jump 166 Percent to $3.5 Billion in Quarter Three
31 Oct 2025 12:40 GMT
… large-scale transactions in the pharma, biotech, and hospital segments.
Capital … models.
Pharma and Biotech Lead the Charge
Pharma and biotech segments emerged … API (Active Pharmaceutical Ingredients) to formulations, contract drug manufacturing operations ( …
-
Calluna Pharma Announces U.S. FDA Orphan Drug Designation Granted to CAL101 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)
31 Oct 2025 12:49 GMT
… --(BUSINESS WIRE)--Calluna Pharma AS, a clinical stage biotechnology company pioneering first … idiopathic pulmonary fibrosis (IPF).
“Orphan drug designation speaks to the importance … face.”
The FDA grants Orphan Drug Designation to support the development …
-
Health Biotech Strengthens Global Footprint at CPHI Frankfurt 2025
31 Oct 2025 12:34 GMT
… high-quality generic and innovative drugs. Its core business is injectables … Founded in 2005, Health Biotech Limited is an India-based pharmaceutical organization with a research- … , syrups, ointments and latest drug delivery systems.
For more information, …
-
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
31 Oct 2025 11:30 GMT
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and …
-
OrbiMed-backed biotech quickly changes CEOs; Adaptimmune co-founder to lead Evaxion
31 Oct 2025 11:28 GMT
About
© 1995-2025